Family history of hormonal cancers and colorectal cancer risk: A case-control study conducted in Ontario

被引:8
作者
Jang, Ji-Hyun [1 ,2 ]
Cotterchio, Michelle [1 ,2 ]
Gallinger, Steven [3 ,4 ]
Knight, Julia A. [2 ,4 ]
Daftary, Darshana [1 ]
机构
[1] Canc Care Ontario, Populat Studies & Surveillance, Toronto, ON M5G 1X3, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto, ON, Canada
[4] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
基金
美国国家卫生研究院;
关键词
colorectal neoplasms; cancer; family history; familial aggregation; case-control study; ESTROGEN PLUS PROGESTIN; REPLACEMENT THERAPY; PROSTATE-CANCER; COLON-CANCER; BREAST-CANCER; POSTMENOPAUSAL WOMEN; ORAL-CONTRACEPTIVES; PARENTAL CANCERS; DEGREE RELATIVES; OVARIAN-CANCER;
D O I
10.1002/ijc.24385
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aggregation of cancers among families with highly penetrant genetic mutations such as hereditary nonpolyposis colorectal cancer is well-described. However, there is a paucity of data regarding familial aggregation of hormonal cancers (cancers of the breast, endometrial, ovarian and prostate) and colorectal cancer (CRC) in the general population. We investigated the association between having a first-degree family history of breast, endometrial, ovarian, or prostate cancer and CRC risk. Population-based CRC cases and controls were recruited by the Ontario Familial Colorectal Cancer Registry (OFCCR). Logistic regression was conducted to obtain odds ratio (OR) estimates and 95% confidence intervals (95% CIs). First-degree family history of breast cancer was associated with a modest, borderline statistically significant increased CRC risk (age-, sex-adjusted OR = 1.2, 95% CI = 1.11, 1.5). The magnitude of CRC risk was greatest if more than one first-degree kin had breast cancer (age-, sex-adjusted OR = 1.7, 95% CI = 1.0, 2.0), as well as if the kin was diagnosed at >50 years of age (age-, sex-adjusted OR = 1.4, 95% CI = 1.1, 1.8). Family history of ovarian cancer was associated with reduced CRC risk (multivariate-adjusted OR = 0.6, 95% CI = 0.3, 1.11). Although statistically significant increases in CRC risk were observed in the age-, sex-adjusted OR estimates for family, history of endometrial and prostate cancers, the associations were no longer significant after multivariate-adjustment. In conclusion, individuals with a first-degree kin with breast cancer may have a modest increased risk for CRC compared to individuals without. (C) 2009 UICC
引用
收藏
页码:918 / 925
页数:8
相关论文
共 64 条
  • [1] [Anonymous], 1997, INT CLASSIFICATION D
  • [2] The risk of breast, endometrial and ovarian cancer in users of hormonal preparations
    Bernstein, L
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (03) : 288 - 296
  • [3] ACCURACY OF FAMILY HISTORY OF CANCER OBTAINED THROUGH INTERVIEWS WITH RELATIVES OF PATIENTS WITH CHILDHOOD SARCOMA
    BONDY, ML
    STROM, SS
    COLOPY, MW
    BROWN, BW
    STRONG, LC
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (01) : 89 - 96
  • [4] Current perspectives on oral contraceptive use
    Burkman, RT
    Collins, JA
    Shulman, LP
    Williams, JK
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (02) : S4 - S12
  • [5] Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer
    Campbell, Peter T.
    Newcomb, Polly
    Gallinger, Steven
    Cotterchio, Michelle
    McLaughlin, John R.
    [J]. CANCER CAUSES & CONTROL, 2007, 18 (07) : 723 - 733
  • [6] Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario
    Carruba, Giuseppe
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (04) : 899 - 911
  • [7] Estrogen plus progestin and colorectal cancer in postmenopausal women
    Chlebowski, RT
    Wactawski-Wende, J
    Ritenbaugh, C
    Hubbell, FA
    Ascensao, J
    Rodabough, RJ
    Rosenberg, CA
    Taylor, VM
    Harris, R
    Chen, C
    Adams-Campbell, LL
    White, E
    Alving, B
    Rossouw, J
    Pottern, L
    Ludlam, S
    McGowan, J
    Prentice, R
    Anderson, G
    LaCroix, A
    Patterson, R
    McTiernan, A
    Cochrane, B
    Hunt, J
    Tinker, L
    Kooperberg, C
    McIntosh, M
    Wang, CY
    Chen, C
    Bowen, D
    Kristal, A
    Stanford, J
    Urban, N
    Weiss, N
    White, E
    Shumaker, S
    Rautaharju, P
    Prineas, R
    Naughton, M
    Stein, E
    Laskarzewski, P
    Cummings, S
    Nevitt, M
    Dockrell, M
    Harnack, L
    Cammarata, F
    Lindenfelser, S
    Psaty, B
    Heckbert, S
    Wassertheil-Smoller, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) : 991 - 1004
  • [8] Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index
    Colditz, GA
    Atwood, KA
    Emmons, K
    Monson, RR
    Willett, WC
    Trichopoulos, D
    Hunter, DJ
    [J]. CANCER CAUSES & CONTROL, 2000, 11 (06) : 477 - 488
  • [9] Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry
    Cotterchio, M
    Manno, M
    Klar, N
    McLaughlin, J
    Gallinger, S
    [J]. CANCER CAUSES & CONTROL, 2005, 16 (07) : 865 - 875
  • [10] Cotterchio M, 2000, Chronic Dis Can, V21, P81